Acquisitions2 Nov 2026, 12:46 pm
Zydus Lifesciences Completes Sterling Biotech API Business Acquisition
AI Summary
Zydus Lifesciences Ltd has successfully completed the acquisition of the API Business of Sterling Biotech Limited. This follows the Business Transfer Agreement signed on September 17, 2024, and the fulfillment of all conditions precedent and closing date adjustments. The acquisition marks a significant step for Zydus Lifesciences in expanding its API capabilities and market presence.
Key Highlights
- Acquisition of Sterling Biotech's API business is now complete.
- All conditions precedent have been met.
- Transaction based on September 17, 2024 agreement.
- Enhances Zydus Lifesciences' API portfolio.
Price Impact
More from ZYDUSLIFE
Management Change2d ago, 7:41 pm
Zydus Lifesciences Appoints Christoph Stoller as President, Int'l Markets
Partnership21 Oct, 6:30 pm
Zydus Lifesciences Partners Prolific Machines for Biologics Manufacturing
USFDA21 Oct, 11:13 am
Zydus Lifesciences Gets USFDA Nod for Estradiol/Levonorgestrel Transdermal System